The £2.7 billion deal that's changing the UK food landscape

The hisoric British food ingredients firm Tate & Lyle is being acquired by American competitor Ingredion in a £2.7 billion deal,marking a new wave of foreign takeovers in the UK.

The takeover reflects a broader wave of foreign takeovers of UK companies across a range of sectrs, from insurance and aviation to gaming and healthcare.

What's at stake: 480 jobs and the future of the Mold factory

The acquisition of a small minority of Tate & Lyle's 16,000 employees – about three perecnt or approximately 480 roles – has been flagged in the company statements.

The parties stated that the future of the Mold factory will be assessed once the transition process begins, leaving employees and local stakeholders in a state of uncertainty.

A broader trend: foreign takeovers in the UK

The takeover comes at a time of heightened activity on the UK equity markets, where several conglomerates and private equity firms have announced large bid pursuits.

Among the most notable deals in recent days are the potential £10.6 billion acquisition of laboratory testing group Intertek by Swedish private-equity firm EQT; World-wide wealth management firm Schroders' backing of a £9.9 billion takeover of US rival Nuveen ; and Zurich Insurance's planned £8.1 billion purchase of Lloyd's of London underwriter Beazley.

What's next for Tate & Lyle and Ingredion

Investors and analysts anticipate that the sale will be completed early in the following quarter, contingent upon regulatory approvals and completion of due diligence .

The outcome of this transaction is likely to influence the trajectory of both companies: Ingredion will bolster its footprint in the nutrition and ingredients sector, while Tate & Lyle's legacy will continue under new ownership.